Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > But I live in Yukon, Texas

<< Previous

Bullboard Posts

Next >>

Comment by Inthepezon Aug 17, 2021 11:15pm

139 Views

Post# 33721899

RE:RE:RE:RE:But I live in Yukon, Texas

It’s past your bedtime boomer lol

YukonJezza wrote:

YukonJezza wrote:

Amigo11 wrote: Phew you're not in Canada.You re not bright enough

smart enough to be in cash amigo

because I stated In from Yukon, Texas you believed me. Give your head a shake simpleton. I'm from Texas but quote in Canadian prices.????